Hepatitis C

A panel of legislators Friday reversed their recommendation of a lifetime ban on hepatitis C drugs for Medicaid patients who don’t comply with their treatment regimen.

Members of the Joint Committee on Home and Community Based Services and KanCare Oversight walked back on the recommendation they made in December  after hearing from Mike Randol, who heads the Kansas Department of Health and Environment’s Division of Health Care Finance.

File photo / Heartland Health Monitor

A legislative oversight committee has approved a controversial set of draft recommendations aimed at reducing the cost of drugs provided to Kansas Medicaid recipients.

The joint committee that oversees the state’s privatized Medicaid program known as KanCare this week tentatively approved recommendations that direct the Kansas Department of Health and Environment to develop policies aimed at slowing a steady increase in the $3 billion program’s pharmacy costs.

Wikimedia -- Creative Commons

A recent report from the Centers for Disease Control and Prevention estimates that only half of Americans identified as having had Hepatitis C ever follow-up with additional screening and treatment. But that’s only part of the problem, according to Bruce Burkett of the Missouri Hepatitis C Alliance. Nearly three in four people who have the disease don’t even know it.

health.jocogov.org

While the Johnson County health department now says cases of whooping cough are on the decline in the region, health officials have noted a rise in another disease in area young adults: Hepatitis C.